Valence Labs Research
CJC-1295 No DAC
GHRH Analogue Research Peptide
- Compound
- CJC-1295 No DAC
- Category
- Research Peptide
- Available Variant
- 10mg
- Research Status
- Research Use Only
Overview
The Valence Labs catalog material is CJC-1295 No DAC, also described as Modified GRF(1-29). It is a GHRH analogue studied in growth hormone-releasing hormone receptor and GH-axis signaling research.
CJC-1295 No DAC is distinct from long-acting, DAC-containing CJC-1295. Multi-day pharmacokinetics and albumin-binding properties described for DAC-containing CJC-1295 should not be attributed to this No-DAC product, and studies of DAC-containing CJC-1295 should not be read as direct studies of Valence CJC-1295 No DAC.
Research Areas
GHRH Analogue Research
CJC-1295 No DAC / Modified GRF(1-29) is studied as a GHRH analogue in laboratory research.
GHRH Receptor / GH-Axis Signaling
Research interest includes GHRH-receptor interaction and related GH-axis signaling questions.
Structure–Activity & Peptide Stability
The Modified GRF(1-29) sequence is examined in structure–activity and peptide-stability research without the Drug Affinity Complex (DAC) modification.
How It Is Being Studied
This page describes CJC-1295 No DAC / Modified GRF(1-29). It does not describe DAC-containing, long-acting CJC-1295.
Published work on long-acting/DAC-containing CJC-1295 is cited below only to mark that distinction. Those studies should not be treated as evidence that the No-DAC catalog product was studied, or that it shares DAC-associated albumin-binding or multi-day pharmacokinetic properties.
Specifications
Catalog details for this product.
- Product Name
- CJC-1295 No DAC
- Category
- Research Peptide
- Variant
- 10mg
- Form
- Documentation pending
- Storage
- Documentation pending
- Purity
- Documentation pending
- Intended Use
- Laboratory research use only
Available Documentation
Documentation will appear here as records are published.
References
Available Product
CJC-1295 No DAC
10mg